In animal models, TRPV4 antagonists such as HC-067047, RN-1734, and GSK2193874 have therapeutic effects on many disorders, including cardiovascular and ocular diseases, osteoarthritis, and bladder hyperactivity. This evidence concerns the gene TRPV4 and osteoarthritis.